Treatment and treatment results for unselected metastatic colorectal cancer patients according to BRAF/KRAS gene analyses (446 cases with BRAF analyses, 442 cases with both BRAF and KRAS analyses). This evidence concerns the gene KRAS and metastatic colorectal cancer.